Who Paid My Doc
Christopher Bui
Hospice and Palliative Medicine Pasadena, CA Medical Doctor
NPI 1376858829 CMS profile 17490
960 E Green St Ste L-07, Pasadena, CA 91106
General payments
$895
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Christopher Bui of Pasadena, CA is reported in the CMS Open Payments database as having received $895 across 14 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $516 | 11 | |
| 2022 | General | $125 | 1 | |
| 2021 | General | $140 | 1 | |
| 2020 | General | $114 | 1 |
Beside peers
- Christopher Bui
- California median
- Middle half of California
- National median
In program year 2025, general payments to Christopher Bui were reported at $0. Among 98,626 California profiles paid that year, the median was $172 and the middle half received between $54 and $610.
Show as a table
| Year | Christopher Bui | California median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $161 | $50–$652 | $163 |
| 2020 | $114 | $114 | $34–$392 | $114 |
| 2021 | $140 | $137 | $41–$509 | $132 |
| 2022 | $125 | $152 | $48–$573 | $149 |
| 2023 | $0 | $162 | $50–$581 | $160 |
| 2024 | $516 | $162 | $52–$583 | $164 |
| 2025 | $0 | $172 | $54–$610 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 9 drugsPart D claims
156
Drug cost
$1,429
Branded share of claims
7.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 36 | $355 | |
| Levothyroxine Sodium | Generic | 14 | $263 | |
| Omeprazole | Generic | 21 | $202 | |
| Oxybutynin Chloride Er Oxybutynin Chloride | Brand | 11 | $158 | |
| Alendronate Sodium | Generic | 15 | $147 | |
| Metformin Hcl | Generic | 19 | $108 | |
| Simvastatin | Generic | 13 | $93 | |
| Lisinopril | Generic | 16 | $63 | |
| Amlodipine Besylate | Generic | 11 | $41 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.
Records
14 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hospice and Palliative Medicine in California
Neil Soni
Hospice and Palliative Medicine · Fountain Valley, CA
Negin Salimi
Hospice and Palliative Medicine · San Diego, CA
Eric Tsu
Hospice and Palliative Medicine · Torrance, CA
Naghmeh Kerendian
Hospice and Palliative Medicine · Beverly Hills, CA
James Stark
Hospice and Palliative Medicine · San Francisco, CA
Arpit Arora
Hospice and Palliative Medicine · West Hollywood, CA
Related records
Hospice and Palliative Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Hospice and Palliative Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.